top of page

EU-GMP designed manufacturing & extraction facility for sale in Southern Italy

State-of-the-art manufacturing and extraction facility in Southern Italy, fully equipped for industrial processing, laboratory analysis, packaging, and secure storage. Ideal for cannabinoid extraction, R&D, or industrial biotech applications. Available for outright sale.

Listing ID:

31615780783

Licence(s) Held:

N/A

Italy flag with cannabis leaves for an EU GMP extraction facility sale.

Seeking outright sale of the land, buildings and equipment. Inquire for more information.

Listing Details:

  • ~3,800+ m² state-of-the-art operational facilities constructed to EU-GMP standards, strategically located in Southern Italy within a well-established industrial zone.

  • Fully turnkey setup with design and infrastructure to meet EU-GMP certification and pharmaceutical-grade standards

  • Recent construction completed in 2021; facility is in excellent condition and has never been commercially operated

  • Land size totals 9,500 m², including green space, parking, and asphalted areas

  • Facility includes offices (600 m²), warehouse and pellet storage (721 m²), and production/lab/office/mezzanine/HVAC areas (approx. 2,934 m²)

  • External greenhouse for primary processing measures 1,080 m² (270 m² considered commercial area)

  • Purpose-built for extraction and processing of active ingredients for pharmaceutical, nutraceutical, and cosmetic applications

  • Also ideally suited for cannabinoid extraction, industrial biotech, and R&D use

  • Facility features include extraction and processing areas, packaging zones, multiple laboratory spaces, secure storage, shipping zones, office areas, and support rooms

  • ~€4 million value for land and building based on recent third-party appraisal

  • ~€7.3 million invested in specialized equipment and systems

  • Equipment includes KPD1500, Capna, and KD10 extraction systems, distillation units, rotavapor, HVAC system, photovoltaic solar array, Agilent LC/MS system, silos, office equipment, and vehicles

  • Facility is equipped with climate control, energy systems, solar panels, and electrical transformers

  • Buyer may benefit from available tax loss carryforwards associated with the facility

  • Ownership is seeking an outright sale of the land, buildings, and equipment as a package

31615780783

Inquiry Form

Thanks for submitting! We have received your message and will get back to you within 24 hours. Until then, you can send an email to info@hydeadvisory.com

Contact-us-deal

NEW CANNABIS BUSINESSES FOR SALE

See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.

Cannabis New/Featured Business Listing - Merger & Acquisition

50517798914

High-Margin German Medical Cannabis Platform & Licensed EU-GMP Gateway

Cannabis New/Featured Business Listing - Merger & Acquisition

Fully licensed, profitable German medical cannabis platform providing immediate market access, certified warehouse/storage facility, and high-margin EU-GMP manufacturing capabilities

Cannabis New/Featured Business Listing - Merger & Acquisition

50240015963

Licensed pharmaceutical distribution platform and market entry hub in Poland for €675K OBO

Cannabis New/Featured Business Listing - Merger & Acquisition

A licensed, operational, GDP-aligned pharmaceutical wholesaler in Poland providing immediate market access for medical cannabis through established distribution channels and controlled-substance authorizations. Company seeks a 51% to 100% equity sale.

Cannabis New/Featured Business Listing - Merger & Acquisition

36324927098

Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner

Cannabis New/Featured Business Listing - Merger & Acquisition

Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential

bottom of page